Persistently lower bone mass and bone turnover among South African children living with well controlled HIV
- PMID: 34127577
- PMCID: PMC8490283
- DOI: 10.1097/QAD.0000000000002990
Persistently lower bone mass and bone turnover among South African children living with well controlled HIV
Abstract
Objective: We evaluated longitudinal trends and associations between bone mass, bone turnover and inflammatory markers among South African children living with HIV (CLHIV) and controls.
Design: We previously reported decreased bone mass among CLHIV independent of marked inflammation and increased bone turnover. The goal of this study was to evaluate longitudinal changes in bone mass, bone turnover and inflammation over 2 years.
Methods: Longitudinal analyses were conducted among 220 CLHIV and 220 controls. Anthropometric measurements, physical activity, antiretroviral regimen, virologic and immunologic status, whole body (WB) and lumbar spine (LS) bone mineral content (BMC) and bone mineral density (BMD) were collected (enrollment, 12 and 24 months). Bone turnover markers including C-telopeptide of type I collagen (CTx) and procollagen type I N-terminal propeptide (P1NP) and inflammatory markers including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble CD14 and high-sensitivity C-reactive protein (hsCRP) were collected at enrollment and 24 months.
Results: Compared with controls, CLHIV had significantly lower mean WB-BMC, WB-BMD, WB-BMC z scores, LS-BMC and LS-BMD as well as lower bone formation (P1NP) and resorption (CTx), and higher hsCRP and soluble CD14 over 24 months. CLHIV on efavirenz (EFV) had consistently lower TNF-alpha and IL-6 compared with those on ritonavir-boosted lopinavir (LPV/r) at all time points.
Conclusion: Over 2 years of follow-up, South African CLHIV had persistently lower bone mass, bone turnover, and macrophage activation. Lower bone mass and higher pro-inflammatory cytokine profiles were consistently observed among those on LPV/r-based compared with EFV-based regimens.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Figures
Comment in
-
Cytokines in HIV infection: different methods of assessment require different interpretations.AIDS. 2022 May 1;36(6):907-908. doi: 10.1097/QAD.0000000000003184. AIDS. 2022. PMID: 35506269 No abstract available.
References
-
- Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, et al.Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 51(2):214–224. - PubMed
-
- Foster C, Judd A, Tookey P, Tudor-Williams G, Dunn D, Shingadia D, et al.Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS patient care and STDs 2009; 23(3):159–166. - PubMed
-
- Sabatier JP, Guaydier-Souquieres G, Laroche D, Benmalek A, Fournier L, Guillon-Metz F, et al.Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10–24 years of age. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996; 6(2):141–148. - PubMed
-
- Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000; 15(11):2245–2250. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials